CSE/METX (CSE/METX)

Canadian Securities Exchange: CSE/METX · CAD

CA$1.06

+0.00 (0.0%)· Recorded snapshot

Market cap	32.2M
Net income (ttm)	-1.4M
EPS (ttm)	-CA$0.05
Shares out	30.4M
Volume	0
Beta	-0.01

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -1.4M
EPS (ttm): -CA$0.05
Market cap: 32.2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-111

P25 n/aP50 n/aP75 n/a

ROIC-74.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/METX indicators

Market & fundamental data

Available fields

136

Groups with data

Currency

CAD

Showing 136 of 136 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Enterprise value	CAD 31.7M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-05-31
First seen	2026-05-10
Fiscal year end	August
Founded	2014
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA5527671054
Last earnings date	2025-11-27
Last refreshed	2026-10-29
Market cap	CAD 32.2M
Next earnings date	2026-11-27
Price	CAD 1.06
Price currency	CAD
Sector	Healthcare
SIC code	8049
Stock price date	2026-10-28
Symbol	cse/METX
Website	https://www.metherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-4.36%
FCF / EV yield	-4.07%
FCF yield	-4.01%
P/B ratio	49.93x
Price / tangible book value	49.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-69%
ROA (5Y)	-90.27%
ROCE	-240.42%
ROE	-111.03%
ROIC	-74.6%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -75,817
Depreciation and amortization	CAD 14,228
EBIT	CAD -1.6M
EBITDA	CAD -1.5M
EPS	CAD -0.05
FCF per share	CAD -0.04
Financing cash flow	CAD 117,692
Free cash flow	CAD -1.3M
Investing cash flow	CAD -75,817
Net borrowing	CAD -66,308
Net cash flow	CAD -1.2M
Net income	CAD -1.4M
Operating income	CAD -1.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD 0.02
Debt / equity	0.04
Interest coverage	-191.74
Long-term assets	CAD 206,321
Long-term liabilities	CAD 0
Net cash (debt)	CAD 509,562
Net cash / market cap	1.58%
Net cash growth	-68.62%
Net debt / equity	-0.79
Piotroski F-Score	1
Property, plant and equipment	CAD 195,429
Shareholders' equity	CAD 645,097
Tangible book value	CAD 645,096
Tangible book value per share	CAD 0.02
Total assets	CAD 795,961
Total cash	CAD 536,518
Total debt	CAD 26,956
Total liabilities	CAD 150,864
WACC	4.23%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 589,640
Current liabilities	CAD 150,864
Current ratio	3.91
Net working capital	CAD -70,786
Quick ratio	3.87
Working capital	CAD 438,776

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-11.85%
Shareholder yield	-11.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 5.09
1D price change	0%
1M price change	-39.43%
1M total return	-39.43%
1W price change	-62.14%
1W total return	-62.14%
1Y price change	-82.18%
1Y return CAGR	-82.21%
1Y total return	-82.18%
20-day SMA	CAD 2.05
200-day SMA	CAD 5.03
3M price change	-64.67%
3M total return	-64.67%
3Y price change	68.92%
3Y return CAGR	19.09%
3Y total return	68.92%
50-day SMA	CAD 2.35
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 8.00
52-week high date	2025-10-23
52-week low	CAD 0.79
52-week low date	2026-06-29
6M price change	-57.6%
6M total return	-57.6%
All-time high	CAD 11.00
All-time high date	2025-03-19
All-time low	CAD 0.05
All-time low date	2023-11-29
Average true range (ATR)	CAD 0.65
Average volume	1.8K
Beta (1Y)	0.2
Beta (2Y)	1.2
Beta (5Y)	-0.01
Change from 52-week high	-86.75%
Change from 52-week low	34.18%
Change from all-time high	-90.36%
Change from all-time low	2,020%
Change from open	0%
Day's gap	0%
High price	CAD 1.06
Low price	CAD 1.06
Monthly RSI	41.49
Open price	CAD 1.06
Previous close	CAD 1.06
Price vs 150-day SMA	-79.19%
Price vs 20-day SMA	-48.37%
Price vs 200-day SMA	-78.91%
Price vs 50-day SMA	-54.86%
Relative volume	0.06
RSI	43.21
Sharpe ratio	1.15
Sortino ratio	2.17
Volume	0
Weekly RSI	40.39
YTD price change	-73.5%
YTD total return	-73.5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13.1M
Shares change (QoQ)	0%
Shares change (YoY)	11.85%
Shares held by insiders	56.69%
Shares outstanding	30.4M

Deeper analysis on CSE/METX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/METX report

Is a complete CSE/METX research report available?

No complete published report is available for cse/METX (CSE/METX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/METX (CSE/METX)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/METX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/METX indicators

Profile and market data

Valuation

Profitability

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/METX

Frequently asked questions